1-11 of 11
Francesco Bertolini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of the Anti-Activin Receptor-Like Kinase 1 (ALK-1) Monoclonal Antibody PF-03446962 in Patients with Advanced Solid Tumors

Laura W. Goff, Roger B. Cohen, Jordan D. Berlin, Filippo G. de Braud, Andrej Lyshchik, Cristina Noberasco, Francesco Bertolini, Marina Carpentieri, Corrado Gallo Stampino, Antonello Abbattista, Erjan Wang, Hossein Borghaei
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (9): 2146–2154.
https://doi.org/10.1158/1078-0432.CCR-15-1622
Published: 01 May 2016
View articletitled, A Phase I Study of the Anti-Activin Receptor-Like Kinase 1 (ALK-1) Monoclonal Antibody PF-03446962 in Patients with Advanced Solid Tumors
Open the PDF for A Phase I Study of the Anti-Activin Receptor-Like Kinase 1 (ALK-1) Monoclonal Antibody PF-03446962 in Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Circulating endothelial cells as a therapeutic marker for docetaxel treatment and combination therapy of docetaxel and thalidomide in a human prostate cancer model

Haiqing Li, Valentina Raia, Francesco Bertolini, William D. Figg
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19_Supplement): PR-10.
Published: 15 August 2014
View articletitled, Circulating endothelial cells as a therapeutic marker for docetaxel treatment and combination therapy of docetaxel and thalidomide in a human prostate cancer model
Journal Articles

About CD45−/CD31+/CD105+ Circulating Cells in Patients with Gynecologic Malignancies—Letter

Francesco Bertolini, Patrizia Mancuso, John V. Heymach
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (5): 1393.
https://doi.org/10.1158/1078-0432.CCR-13-2855
Published: 02 March 2014
View articletitled, About CD45−/CD31+/CD105+ Circulating Cells in Patients with Gynecologic Malignancies—Letter
Open the PDF for About CD45−/CD31+/CD105+ Circulating Cells in Patients with Gynecologic Malignancies—Letter in another window
Journal Articles

Therapeutic Effect of Lenalidomide in a Novel Xenograft Mouse Model of Human Blastic NK Cell Lymphoma/Blastic Plasmacytoid Dendritic Cell Neoplasm

Alice Agliano, Ines Martin-Padura, Paola Marighetti, Giuliana Gregato, Angelica Calleri, Celia Prior, Miriam Redrado, Alfonso Calvo, Francesco Bertolini
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (19): 6163–6173.
https://doi.org/10.1158/1078-0432.CCR-11-0212
Published: 02 October 2011
View articletitled, Therapeutic Effect of Lenalidomide in a Novel Xenograft Mouse Model of Human Blastic NK Cell Lymphoma/Blastic Plasmacytoid Dendritic Cell Neoplasm
Open the PDF for Therapeutic Effect of Lenalidomide in a Novel Xenograft Mouse Model of Human Blastic NK Cell Lymphoma/Blastic Plasmacytoid Dendritic Cell Neoplasm in another window
Includes: Supplementary data
Journal Articles

Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab

Angelica Calleri, Anna Bono, Vincenzo Bagnardi, Jessica Quarna, Patrizia Mancuso, Cristina Rabascio, Silvia Dellapasqua, Elisabetta Campagnoli, Yuval Shaked, Aron Goldhirsch, Marco Colleoni, Francesco Bertolini
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (24): 7652–7657.
https://doi.org/10.1158/1078-0432.CCR-09-1493
Published: 14 December 2009
View articletitled, Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab
Open the PDF for Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab in another window
Journal Articles

Quantification of Circulating Endothelial Cells by Flow Cytometry

Patrizia Mancuso, Angelica Calleri, Francesco Bertolini, Carlo Tacchetti, John V. Heymach, David R. Shalinsky
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (10): 3640.
https://doi.org/10.1158/1078-0432.CCR-09-0591
Published: 18 May 2009
View articletitled, Quantification of Circulating Endothelial Cells by Flow Cytometry
Open the PDF for Quantification of Circulating Endothelial Cells by Flow Cytometry in another window
Journal Articles

Validation of a Standardized Method for Enumerating Circulating Endothelial Cells and Progenitors: Flow Cytometry and Molecular and Ultrastructural Analyses

Patrizia Mancuso, Pierluigi Antoniotti, Jessica Quarna, Angelica Calleri, Cristina Rabascio, Carlo Tacchetti, Paola Braidotti, Hua-Kang Wu, Amado J. Zurita, Luca Saronni, John B. Cheng, David R. Shalinsky, John V. Heymach, Francesco Bertolini
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (1): 267–273.
https://doi.org/10.1158/1078-0432.CCR-08-0432
Published: 31 December 2008
View articletitled, Validation of a Standardized Method for Enumerating Circulating Endothelial Cells and Progenitors: Flow Cytometry and Molecular and Ultrastructural Analyses
Open the PDF for Validation of a Standardized Method for Enumerating Circulating Endothelial Cells and Progenitors: Flow Cytometry and Molecular and Ultrastructural Analyses in another window
Journal Articles

High-Dose Celecoxib and Metronomic “Low-dose” Cyclophosphamide Is an Effective and Safe Therapy in Patients with Relapsed and Refractory Aggressive Histology Non–Hodgkin's Lymphoma

Rena Buckstein, Robert S. Kerbel, Yuval Shaked, Rakesh Nayar, Cindy Foden, Ruth Turner, Christine R. Lee, Diane Taylor, Liying Zhang, Shan Man, Sylvain Baruchel, Diana Stempak, Francesco Bertolini, Michael Crump
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (17): 5190–5198.
https://doi.org/10.1158/1078-0432.CCR-06-0474
Published: 01 September 2006
View articletitled, High-Dose Celecoxib and Metronomic “Low-dose” Cyclophosphamide Is an Effective and Safe Therapy in Patients with Relapsed and Refractory Aggressive Histology Non–Hodgkin's Lymphoma
Open the PDF for High-Dose Celecoxib and Metronomic “Low-dose” Cyclophosphamide Is an Effective and Safe Therapy in Patients with Relapsed and Refractory Aggressive Histology Non–Hodgkin's Lymphoma in another window
Journal Articles

Mammaglobin Expression in Leukapheresis Products Is a Predictive Marker of Poor Prognosis in Women with High-Risk Breast Cancer

Pier Francesco Ferrucci, Cristina Rabascio, Chiara Mazzetta, Emilia Cocorocchio, Alberto Agazzi, Anna Vanazzi, Saverio Cinieri, Fedro A. Peccatori, Mara Paolucci, Francesco Bertolini, Giovanni Martinelli
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (18): 6039–6046.
https://doi.org/10.1158/1078-0432.CCR-03-0453
Published: 24 September 2004
View articletitled, Mammaglobin Expression in Leukapheresis Products Is a Predictive Marker of Poor Prognosis in Women with High-Risk Breast Cancer
Open the PDF for Mammaglobin Expression in Leukapheresis Products Is a Predictive Marker of Poor Prognosis in Women with High-Risk Breast Cancer in another window
Journal Articles

Stroma Cells: A Novel Target of Herceptin Activity

Chiara Corsini, Patrizia Mancuso, Saki Paul, Alessandra Burlini, Giovanni Martinelli, Giancarlo Pruneri, Francesco Bertolini
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (5): 1820–1825.
Published: 01 May 2003
View articletitled, Stroma Cells: A Novel Target of Herceptin Activity
Open the PDF for Stroma Cells: A Novel Target of Herceptin Activity in another window
Journal Articles

Continuous Infusion of Endostatin Inhibits Differentiation, Mobilization, and Clonogenic Potential of Endothelial Cell Progenitors

Manuela Capillo, Patrizia Mancuso, Alberto Gobbi, Silvia Monestiroli, Giancarlo Pruneri, Chiara Dell’Agnola, Giovanni Martinelli, Leonard Shultz, Francesco Bertolini
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (1): 377–382.
Published: 01 January 2003
View articletitled, Continuous Infusion of Endostatin Inhibits Differentiation, Mobilization, and Clonogenic Potential of Endothelial Cell Progenitors
Open the PDF for Continuous Infusion of Endostatin Inhibits Differentiation, Mobilization, and Clonogenic Potential of Endothelial Cell Progenitors in another window